Treatment of systemic mast-cell disease with cladribine [3]

New England Journal of Medicine

Volumn 344, Issue 4, 2001, Pages 307-309

  Tefferi, A ^a   Li, C Y ^a   Butterfield, J H ^a   Hoagland, H C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CLADRIBINE;

ADULT; BONE MARROW BIOPSY; CASE REPORT; FEMALE; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MAST CELL DISEASE; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYSTEMIC MASTOCYTOSIS; TREATMENT OUTCOME; URTICARIA PIGMENTOSA;

EID: 0035945661     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200101253440415     Document Type: Letter

References (2)

1. Cladribine activity in adult Langerhans-cell histiocytosis
2. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)